Team D Sight D sight has a multidisciplinary and highly committed human team which includes scientific and clinical key opinion leaders, with expertise in diabetic retinopathy and diabetes. as well as experts in technology transfer and innovation in the biomedical and pharmaceutical sector. Our user centric design simplifies multi criteria evaluations, making them accessible to all team members. benefit from sophisticated algorithms and tools that provide deep insights, helping you prioritize and rank conflicting criteria effectively. test the robustness of your decisions.
D Sight Portfolio D sight employs 7 employees. the d sight management team includes yves de smet (founder), quantin hayez (managing partner and co founder), and 周华珍 (会计). looking for a particular d sight employee's phone or email?. D sight is a company that specializes in decision support software and associated services in the domains of project prioritization, supplier selection and collaborative decision making. Explore d sight's in depth company profile, including funding details, key investors, leadership, and competitors. D sight is a spin off from the université libre de bruxelles offering decision aid solutions. the company is specialized in the field of multi criteria decision aid and develops dedicated software, training material and consultancy services in this area.
D Sight Explore d sight's in depth company profile, including funding details, key investors, leadership, and competitors. D sight is a spin off from the université libre de bruxelles offering decision aid solutions. the company is specialized in the field of multi criteria decision aid and develops dedicated software, training material and consultancy services in this area. D sight originated from over fifteen years of research conducted by the diabetes and metabolism research group at vhir, with the aim of translating advances in neuroscience into clinical ophthalmology practice. Discover current leadership team members including founders, ceo, other executives and board directors. D sight is a spin off company from vall d’hebron institute of research (vhir) lead by an experienced and committed team dedicated to the discovery and development of new innovative treatments for neurodegenerative diseases of the retina. In this context, d sight, a clinical stage spin off of the vall d’hebron research institute (vhir), is developing the first eye drop formulation for the early treatment of diabetic retinopathy.
D Sight D sight originated from over fifteen years of research conducted by the diabetes and metabolism research group at vhir, with the aim of translating advances in neuroscience into clinical ophthalmology practice. Discover current leadership team members including founders, ceo, other executives and board directors. D sight is a spin off company from vall d’hebron institute of research (vhir) lead by an experienced and committed team dedicated to the discovery and development of new innovative treatments for neurodegenerative diseases of the retina. In this context, d sight, a clinical stage spin off of the vall d’hebron research institute (vhir), is developing the first eye drop formulation for the early treatment of diabetic retinopathy.
Comments are closed.